Last checked at 12 Nov 2021 08:17
LONDON BRIEFING: AstraZeneca holds guidance as vaccine revenue surges
LONDON BRIEFING: AstraZeneca holds guidance as vaccine revenue surges
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News3
AZN Share
Chat
AZN Share
Trades16,417
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
12,050.00
Bid:
12,038.00
Ask:
12,040.00
Change:
-106.00 (-0.87%)
Spread:
2.00 (0.017%)
Open:
12,092.00
High:
12,178.00
Low:
12,010.00
Prev. Close:
12,156.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.12 Nov 2021 07:58
LONDON MARKET PRE-OPEN: Astra revenue up; Wood reviews Consulting unit
LONDON MARKET PRE-OPEN: Astra revenue up; Wood reviews Consulting unit
Read more12 Nov 2021 07:32
UPDATE 4-AstraZeneca starts to make modest profit from COVID-19 vaccine
(Repeats to fix story link)* Vaccine adds one cent to Q3 EPS* Co expects profit from shot to offset antibody costs* Q3 sales jump 47%, but costs bite* 2021 sales outlook improved, profit maintained* Shares down 4.5%By Pushkala Aripaka and Ludwig Burg...
Read more12 Nov 2021 07:32
UPDATE 4-AstraZeneca starts to make modest profit from COVID-19 vaccine
* Vaccine adds one cent to Q3 EPS* Co expects profit from shot to offset antibody costs* Q3 sales jump 47%, but costs bite* 2021 sales outlook improved, profit maintained* Shares down 4.5% (Releads, adds CEO comment)By Pushkala Aripaka and Ludwig Bu...
Read more12 Nov 2021 07:13
AstraZeneca makes over $1 bln in Q3 vaccine sales, small profit
Nov 12 (Reuters) - AstraZeneca on Friday posted $1.05 billion in COVID-19 vaccine sales for the third quarter and the not-for-profit vaccine added one cent to profit in the period, while the company reiterated its forecasts for 2021.(Reporting by ...
Read more12 Nov 2021 07:03
AstraZeneca holds guidance as Covid vaccine turns profitable
(Sharecast News) - AstraZeneca on Friday reported $1.05bn in third-quarter Covid vaccine sales as the not-for-profit drug added 1% to earnings in the period, while the company reiterated annual forecasts for 2021.
Read more11 Nov 2021 14:15
Friday preview: US consumer confidence, AstraZeneca in focus
(Sharecast News) - Financial markets' focus at the end of the week will shift back towards the US.
Read more10 Nov 2021 12:08
UPDATE 2-Valneva shares soar on EU deal for COVID-19 vaccine
(Adds detail)PARIS, Nov 10 (Reuters) - French vaccines company Valneva's share price jumped more than 20% on Wednesday after it won European Commission approval for a deal under which it would supply up to 60 million doses of its COVID-19 vaccine...
Read more10 Nov 2021 12:08
UPDATE 1-Valneva shares soar after winning EU COVID-19 vaccine deal
(Adds share price, context)PARIS, Nov 10 (Reuters) - French vaccines company Valneva saw it shares jump more than 20% after it won approval from the European Commission for a deal under which it would supply up to 60 million doses of VLA2001, its ...
Read more10 Nov 2021 10:05
UPDATE 2-Weaker pound, banks lift FTSE 100; M&S surges on forecast hike
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* M&S surges on first-half profit beat and FY outlook hike* Broadcaster ITV jumps on strong outlook for ad revenue* Halfords rises after upgr...
Read more10 Nov 2021 09:30
LONDON BROKER RATINGS: Four banks positive on Oxford Nanopore
LONDON BROKER RATINGS: Four banks positive on Oxford Nanopore
Read more9 Nov 2021 15:39
UPDATE 3-AstraZeneca to set up division for vaccines and antibody therapies
* News comes after review of vaccine operations* COVID-19 shot has suffered setbacks during pandemic* Company has antibody therapy proven to prevent infection* Move shows company sees future for COVID-19 vaccine beyond pandemic - analyst (Adds deta...
Read more9 Nov 2021 15:39
UPDATE 2-AstraZeneca to set up division for vaccines and antibody therapies
* News comes after review of vaccine operations* COVID-19 shot has suffered setbacks during pandemic* Company has antibody therapy proven to prevent infection (Adds details and bullet points)By Pushkala AripakaNov 9 (Reuters) - AstraZeneca is creati...
Read more9 Nov 2021 15:39
UPDATE 4-AstraZeneca to set up division for vaccines and antibody therapies
* News comes after review of vaccine operations* COVID-19 shot has suffered setbacks during pandemic* Company has antibody therapy proven to prevent infection* Move shows company sees future for COVID-19 vaccine beyond pandemic - analyst (Adds new ...
Read more9 Nov 2021 15:39
UPDATE 1-AstraZeneca to create separate division for vaccines, antibody therapies
(Adds detail, background)Nov 9 (Reuters) - AstraZeneca is creating a separate division for vaccines and antibody therapies to be led by senior executive Iskra Reic, the drugmaker said on Tuesday, as it builds focus on its COVID-19 shot and develop...
Read more